.png){kind=icon}
返回
mRNA Technology and Mucosal Immunization
.png){kind=icon}
OA
AI
DOI：10.3390/vaccines12060670.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Current mRNA vaccines are mainly administered via intramuscular injection, which induces good systemic immunity but limited mucosal immunity. Achieving mucosal immunity through mRNA vaccination could diminish pathogen replication at the entry site and reduce interhuman transmission. However, delivering mRNA vaccines to mucosae faces challenges like mRNA degradation, poor entry into cells, and reactogenicity. Encapsulating mRNA in extracellular vesicles may protect the mRNA and reduce reactogenicity, making mucosal mRNA vaccines possible. Plant-derived extracellular vesicles from edible fruits have been investigated as mRNA carriers. Studies in animals show that mRNA vehiculated in orange-derived extracellular vesicles can elicit both systemic and mucosal immune responses when administered by the oral, nasal, or intramuscular routes. Once lyophilized, these products show remarkable stability. The optimization of mRNA to improve translation efficiency, immunogenicity, reactogenicity, and stability can be obtained through adjustments of the 5 ' cap region, poly-A tail, codons selection, and the use of nucleoside analogues. Recent studies have also proposed self-amplifying RNA vaccines containing an RNA polymerase as well as circular mRNA constructs. Data from parenterally primed animals demonstrate the efficacy of nasal immunization with non-adjuvanted protein, and studies in humans indicate that the combination of a parenteral vaccine with the natural exposure of mucosae to the same antigen provides protection and reduces transmission. Hence, mucosal mRNA vaccination would be beneficial at least in organisms pre-treated with parenteral vaccines. This practice could have wide applications for the treatment of infectious diseases.
Keyword:
mRNA vaccines
mRNA constructs
systemic immunity
mucosal immunity
combined vaccination
extracellular vesicles
plant-derived extracellular vesicles
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.4
论文数:
1.0W
被引数:
2.6W
机构
引用论文
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.png)
NATURE MEDICINE
NATURE MEDICINEIF50
PREAI
分享收藏Lipid-Based Nanoparticle Functionalization with Coiled-Coil Peptides for In Vitro and In Vivo Drug Delivery具有卷曲螺旋肽的基于脂质的纳米颗粒功能化，用于体外和体内药物递送OAAI
OAAI分享收藏American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease
OAAI
OAAI分享收藏Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles细胞外囊泡-脂质体杂化纳米颗粒的功能性siRNA递送OAAI
OAAI分享收藏Translational recoding: canonical translation mechanisms reinterpretedNUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAI分享收藏
查看更多内容